Used in pharmaceutical research as a chiral building block for synthesizing biologically active compounds, particularly those targeting the central nervous system. Its structural features make it valuable in developing potential treatments for neurological disorders such as depression, anxiety, and addiction. The compound serves as a key intermediate in the synthesis of selective receptor ligands, including those acting on dopamine, serotonin, and nicotinic acetylcholine receptors. Due to its stereochemistry, the (R)-enantiomer is often preferred in drug design for enhanced target specificity and reduced side effects. Also explored in the development of novel analgesics and cognitive enhancers.